$ABBV Income Statement | Understand Stock

$ABBV

$286.32 -$0.42 (0.15%) Live

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net revenues
Cost of products sold
Selling, general and administrative
Research and development
Acquired IPR&D and milestones
Other operating income
Total operating costs and expenses
Operating earnings
Interest expense, net
Net foreign exchange loss
Other expense, net
Earnings before income tax expense
Income tax expense (benefit)
Net earnings
Net earnings attributable to noncontrolling interest
Net earnings attributable to AbbVie Inc.
Per share data
Basic earnings per share (in dollars per share)
Diluted earnings per share (in dollars per share)
Weighted-average basic shares outstanding (in shares)
Weighted-average diluted shares outstanding (in shares)

Comments